UK MS Patient Wins £70K After Drug Causes Gambling Addiction
UK MS Patient Wins £70K After Drug Causes Gambling Addiction
A patient suffering from Multiple Sclerosis (MS) in the UK has been awarded a settlement of £70,000 (approximately US$89,000) from the National Health Service (NHS). This compensation comes in light of his claim that a medication prescribed to manage his condition ignited a serious gambling addiction.
Ropinirole, a medication typically used to treat Parkinson’s disease and restless legs syndrome—which is a common symptom associated with MS—transformed Philip Stevens’ leisure activities into all-consuming obsessions. According to reports from The Independent, Stevens found himself spending thousands of pounds on online gambling platforms, losing all sense of enjoyment and control.
The Effects of Ropinirole
The lawsuit filed by Philip Stevens, a resident of Hampshire, England, describes how the 66-year-old developed an impulse control disorder (ICD) after beginning treatment with Ropinirole in 2017. His compulsive behavior extended beyond gambling; he also exhibited a tendency toward excessive shopping, purchasing expensive clothing without restraint.
Impulse control disorder is a recognized side effect of Ropinirole, which is frequently prescribed in both the UK and the United States. In the UK, the NHS advises patients to consult a specialist if they experience any uncontrolled behaviors after starting this medication. Unfortunately, Stevens claims he was never warned about such severe risks.
A Downward Spiral
Stevens initially engaged in betting on horse races, placing modest wagers where he felt he had a realistic chance of winning. However, under the influence of Ropinirole, his gambling behavior escalated drastically. He began waking in the night to place reckless bets, losing interest in actual winnings.
Previously enjoyed hobbies like fishing morphed into compulsive rituals as he started embarking on three-day fishing trips weekly. “The activities that once brought me joy feel void of happiness; guilt looms over every moment. I am no longer the person I used to be before Ropinirole entered my life,” he lamented.
Withdrawal Challenges
In October 2021, Stevens disclosed his gambling issues to a neurologist, who advised him to stop the medication immediately. Unfortunately, he faced severe withdrawal symptoms including extreme fatigue, paranoia, and intense hallucinations that left him unable to recognize his family.
Concerns about prescription medications like Ropinirole affecting patients’ impulse control have been ongoing. Notably, Stevens’ legal team previously obtained a similar settlement from the NHS back in 2013 for another patient who experienced compulsive gambling and shopping behaviors due to the same medication.
According to Casino.org, more than 635 lawsuits have been filed in the US against the antidepressant Aripiprazole (known as Abilify), linking it to various impulsive disorders.
Conclusion
Philip Stevens’ case sheds light on the serious side effects of Ropinirole medication, prompting discussions on the importance of patient education regarding prescription drugs. As more individuals come forward with similar claims, there is an urgent need for better communication and warnings about the potential risks associated with medications like Ropinirole.
